Bridgeway Capital Management, LLC Innoviva, Inc. Transaction History

Bridgeway Capital Management, LLC

$3.75 Billion
Q1 2025

A detailed history of Bridgeway Capital Management, LLC transactions in Innoviva, Inc. stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 162,028 shares of INVA stock, worth $3.1 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

162,028

Previous 185,859 12.82%

Holding current value

$3.1 Million

Previous $3.22 Million 8.9%

% of portfolio

0.08%

Previous 0.08%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$17.21 - $18.98 $410,131 - $452,312	-23,831 Reduced 12.82%	162,028 $2.94 Million
Q4 2024 Feb 14, 2025	SELL	$17.35 - $20.32 $2.42 Million - $2.83 Million	-139,295 Reduced 42.84%	185,859 $3.22 Million
Q3 2024 Nov 14, 2024	SELL	$16.33 - $20.04 $3.81 Million - $4.67 Million	-233,122 Reduced 41.76%	325,154 $6.28 Million
Q2 2024 Aug 14, 2024	BUY	$14.4 - $16.4 $277,344 - $315,864	19,260 Added 3.57%	558,276 $9.16 Million
Q1 2024 May 15, 2024	BUY	$14.56 - $16.78 $275,038 - $316,974	18,890 Added 3.63%	539,016 $8.21 Million
Q4 2023 Feb 14, 2024	BUY	$12.32 - $16.27 $256,514 - $338,757	20,821 Added 4.17%	520,126 $8.34 Million
Q3 2023 Nov 14, 2023	BUY	$12.37 - $13.89 $213,036 - $239,213	17,222 Added 3.57%	499,305 $6.49 Million
Q2 2023 Aug 14, 2023	BUY	$11.39 - $13.72 $76,973 - $92,719	6,758 Added 1.42%	482,083 $6.14 Million
Q1 2023 May 15, 2023	BUY	$10.73 - $13.6 $1.4 Million - $1.77 Million	130,145 Added 37.7%	475,325 $5.35 Million
Q4 2022 Feb 14, 2023	BUY	$11.8 - $13.78 $2.24 Million - $2.61 Million	189,680 Added 121.98%	345,180 $4.57 Million
Q3 2021 Nov 15, 2021	BUY	$13.06 - $17.24 $1.86 Million - $2.45 Million	142,100 Added 1060.45%	155,500 $2.6 Million
Q2 2021 Aug 16, 2021	SELL	$11.45 - $13.96 $297,700 - $362,960	-26,000 Reduced 65.99%	13,400 $180,000
Q1 2021 May 17, 2021	BUY	$11.06 - $12.87 $66,360 - $77,220	6,000 Added 17.96%	39,400 $471,000
Q4 2020 Feb 16, 2021	BUY	$9.33 - $12.48 $36,387 - $48,672	3,900 Added 13.22%	33,400 $414,000
Q3 2020 Nov 16, 2020	BUY	$10.33 - $14.49 $28,924 - $40,572	2,800 Added 10.49%	29,500 $308,000
Q2 2020 Aug 14, 2020	SELL	$11.49 - $15.26 $47,109 - $62,566	-4,100 Reduced 13.31%	26,700 $373,000
Q1 2020 May 15, 2020	SELL	$8.11 - $15.23 $53,525 - $100,518	-6,600 Reduced 17.65%	30,800 $362,000
Q4 2019 Feb 14, 2020	SELL	$10.28 - $14.38 $83,268 - $116,478	-8,100 Reduced 17.8%	37,400 $530,000
Q3 2019 Nov 14, 2019	SELL	$10.05 - $14.55 $51,255 - $74,205	-5,100 Reduced 10.08%	45,500 $480,000
Q2 2019 Aug 14, 2019	BUY	$13.1 - $14.95 $662,860 - $756,470	50,600 New	50,600 $737,000

Others Institutions Holding INVA

# of Institutions

256

Shares Held

75M

Call Options Held

2.3K

Put Options Held

2.4K

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.

Account

Bridgeway Capital Management, LLC Innoviva, Inc. Transaction History